Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.14 USD -1.45%
Market Cap: 1.2B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Aurinia Pharmaceuticals Inc
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aurinia Pharmaceuticals Inc
Accounts Payable Peer Comparison

Comparables:
B
DRUG
TH
RPTX
COV
EDT

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Accounts Payable
$8.9m
CAGR 3-Years
39%
CAGR 5-Years
-8%
CAGR 10-Years
14%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Accounts Payable
CA$596.6k
CAGR 3-Years
63%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Accounts Payable
$23.8m
CAGR 3-Years
-12%
CAGR 5-Years
2%
CAGR 10-Years
17%
Repare Therapeutics Inc
NASDAQ:RPTX
Accounts Payable
$2.4m
CAGR 3-Years
1%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Covalon Technologies Ltd
XTSX:COV
Accounts Payable
CA$3.8m
CAGR 3-Years
-3%
CAGR 5-Years
-7%
CAGR 10-Years
13%
Spectral Medical Inc
TSX:EDT
Accounts Payable
CA$3m
CAGR 3-Years
31%
CAGR 5-Years
34%
CAGR 10-Years
N/A

See Also

What is Aurinia Pharmaceuticals Inc's Accounts Payable?
Accounts Payable
8.9m USD

Based on the financial report for Sep 30, 2024, Aurinia Pharmaceuticals Inc's Accounts Payable amounts to 8.9m USD.

What is Aurinia Pharmaceuticals Inc's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
14%

Over the last year, the Accounts Payable growth was 0%. The average annual Accounts Payable growth rates for Aurinia Pharmaceuticals Inc have been 39% over the past three years , -8% over the past five years , and 14% over the past ten years .

Back to Top